A Western blot analysis performed on subfractionated U-118 and U-87 glioma cells following TNF treatment demonstrated that pP65-Ser536 was upregulated in the cytoplasmic fraction of Ctrl clones compared to CSMD1-overexpressing clones. This evidence concerns the gene TNF and central nervous system cancer.